Maximizing Sales Force Effectiveness: Pharma Talk Show Webinar Series

Pharma Insights continued its exploration into the crucial aspects of Sales Force Effectiveness (SFE) in the pharmaceutical and healthcare industries during its sixth episode. Hosted by Platforce’s Head of Marketing, Stefan Repin, and Events Manager, Juliana Maria Kreisel, this session provided a deep dive into the metrics, KPIs, and strategies vital for enhancing sales force performance.

Understanding Key Components of Salesforce Effectiveness

The conversation highlighted the importance of adapting sales strategies to local contexts. In different markets, the approach to sales force effectiveness (SFE) can vary significantly, necessitating a deep understanding of local regulations, healthcare practices, and patient needs to tailor strategies accordingly.

The episode began with a comprehensive discussion of the foundational components that drive SFE across various markets. The panel featured speakers:

  • Mohamed AbdElRahman Bakr, Sales Force Effectiveness Manager, LIPTIS Egypt,
  • Lucas Hrovat, Sr. Manager of Commercial Execution for LATAM & Canada at Abbott
  • Nuno Melo Moreira, a seasoned consultant in Pharmaceuticals and Healthcare, shared their expertise on how tailored strategies can address varied customer needs effectively. 

Watch the full webinar recording here:

Metrics and KPIs for Measuring Effectiveness

The webinar focused on measuring the effectiveness of sales strategies. Mohamed AbdElRahman Bakr discussed the various KPIs used to gauge success, emphasizing that a robust set of metrics is crucial not only for reaching targets but also for fostering meaningful engagements with healthcare providers. The metrics include coverage and frequency of contact, sales performance, and customer satisfaction levels.

The Role of Technology in Enhancing SFE

The panel also examined the transformative role of modern technologies like AI and CRM systems in refining sales strategies. By leveraging AI and CRM tools, sales teams can customize their approaches based on real-time data, thus enhancing both efficiency and responsiveness to the needs of healthcare providers. These technologies enable a more proactive stance, allowing sales representatives to anticipate and meet the needs of their clients more effectively.

Virtual Medical Reps and Their Growing Importance

The rise of virtual medical representatives was another key topic, especially given the context of the COVID-19 pandemic. The shift to digital platforms has become imperative, prompting sales teams to quickly adapt and utilize virtual tools to maintain and build relationships with healthcare professionals. This transition has underscored the need for agility and adaptability in sales strategies.

Sales Force Contributions to Growth

Towards the end of the webinar, the discussion shifted to the significant contributions of effectively managed sales forces to the overall growth and expansion of pharmaceutical companies. Nuno Melo Moreira emphasized the importance of aligning sales strategies with broader business objectives to ensure that every team member is informed and aligned with the company’s growth targets. This alignment helps in creating a cohesive effort towards achieving business goals.

Final Thoughts

This episode of the Pharma Insights Talk Show provided valuable insights into optimizing sales force effectiveness through strategic planning, precise metrics, and the integration of advanced technologies. As the pharmaceutical industry continues to evolve, such discussions are crucial for staying competitive in a dynamic market. The integration of technology, adaptation to local market needs, and the rise of virtual engagement are key trends that will shape the future of sales force effectiveness in the pharmaceutical industry.

About Platforce

Platforce’s cloud-based CRM and CLM makes full sales cycle management for Pharmaceutical and Life Science companies completely painless. Book a demo of Platforce with our team to learn more!

Sales and Marketing Strategies: Pharma Talk Show Webinar Series

Pharma Insights Talk Show hosted an engaging discussion on the nuanced integration of sales and marketing strategies to enhance healthcare professional (HCP) engagement. The episode, moderated by Juliana Maria Kreisel and Stefan Repin from Platforce, featured insights from Mehrnaz Campbell and Harmeet Seth, seasoned experts in omnichannel marketing and data-driven strategies.

Watch the full webinar recording:

Crafting Seamless Interactions Between Sales and Marketing

The webinar spotlighted the critical need for integration between sales and marketing within the pharmaceutical industry. Mehrnaz Campbell reflected on the evolving dynamics in this field, suggesting a holistic approach to fostering interaction between sales and marketing teams, aimed at improving both engagement and outcomes in healthcare:

“And our purpose really is about unleashing the human potential to create a healthier world. My vision is to inspire pharma commercial teams and marketing teams to shift from being the message bearers to becoming the HCP Advisors. We do this through our market access and sales pull-through strategies that we provide for our clients, but we also do this through our digital brands. And we help individuals and teams to achieve exponential growth both professionally and personally, and help them feel proud and whilst they’re having fun doing the work that is really valuable.”

Harmeet Seth addressed the importance of data-driven strategies in ensuring effective integration: “Digital engagement, multichannel, omnichannel — whatever you wanna call it, my whole background supports the need for integrated approaches that are both innovative and responsive to the real-time dynamics of the marketplace.”

Leveraging Omnichannel Strategies for Enhanced Engagement

The speakers delved into the mechanics of omnichannel strategies, where Mehrnaz shared insights from her book, “The Omni Advantage.” She discussed how behavioral change could be accelerated through tailored sales engagements that respect the preferred channels and content styles of HCPs:

“The Omni Advantage is not about technology is about people and how can we can bring people medical marketing and sales together on this journey so we can actually be the trusted advisors for healthcare professionals […]”

Harmeet added that a good approach to omnichannel strategies requires thinking and understanding the specific needs of HCPs and crafting messages that not only reach them where they are but also resonate on a deeper level.

The Role of Feedback in Content Strategy

A substantial part of the discussion focused on the critical role of feedback in refining marketing strategies to enhance HCP engagement. Harmeet Seth highlighted how essential feedback is in bridging the gap between sales and marketing. “I think we need to be getting them engaged a lot more,” noted Harmeet, referring to sales teams’ involvement in the feedback process. “The second thing that I always focus on is when we’re producing content, be sure to provide the flexibility for the reps to use what content they need.”

Mehrnaz Campbell also emphasized the transformative impact of incorporating real-time feedback into marketing strategies: “I think by working more much more closely between sales and marketing, we can align better with the HCP’s needs, and that’s why, I think that feedback loop is really important”.

Strategic Takeaways and Future Directions

As the webinar concluded, the panellists agreed on the critical need for industries to adapt swiftly to the changing digital landscape. The future of pharma marketing lies in our ability to not only predict but also to quickly respond to the evolving needs of healthcare professionals through integrated sales and marketing strategies.

About Platforce

Platforce’s cloud-based CRM and CLM makes full sales cycle management for Pharmaceutical and Life Science companies completely painless. Book a demo of Platforce with our team to learn more!

Embracing Digital Transformation in Latin America: Pharma Talk Show Webinar Series

Insights from the Pharma Insights Talk Show

We explored Pharma Digital Transformation in Latin America alongside industry experts and professionals in one of the Pharma Talk Show webinars. Below, we highlight the insights shared in this webinar, including strategies for local Latin American markets, team training, and collaboration for sustainable growth.

In this episode of Pharma Insights, the panel explored digital transformation as a phenomenon sweeping through the pharmaceutical industry in Latin America. The region’s unique socio-economic landscape presents both opportunities and challenges in adopting digital technologies. This session highlighted the diverse approaches and strategies being implemented to navigate this transformation successfully.

💬 Speakers and Moderators

🔹 Sandra Sanchez-Oldenhage, President & CEO at PharmAdvice / Independent Board Member

🔹 Claudia Adreani, Director / Consultant at Belly Slide Consulting

🔹 Susana Bento, Global Omnichannel Operations Lead at Grünenthal

🔹 Adrián de Jesús Pérez Castillo, Marketing Manager at Grupo SOMAR

🎙️ Moderated by Juliana Maria Kreisel from Platforce

Watch the full webinar recording: 

The Digitalization Journey: Varied Paces and Strategies

Digitalization in Latin America’s pharmaceutical industry is not a uniform process; it varies significantly across the region. Countries like Chile and Uruguay have made substantial progress, benefiting from vast internet access and advanced technological infrastructures. In contrast, nations like Bolivia and Paraguay are facing significant difficulties due to a limited digital infrastructure. This disparity necessitates customized strategies that address specific local needs, fostering more effective and sustainable digital transformation. 

The pre-existing momentum towards digital transformation in the region, which was significantly accelerated by the pandemic:

“I think that digitalization in Latin America was promoted a little before the pandemic. I think the pandemic catapulted it and accelerated it, but I think there are factors before that.”, said Sandra Sanchez-Oldenhage.

One of the critical challenges highlighted in the discussion is the region’s infrastructure limitations. Many areas still lack the necessary technological framework to support advanced digital solutions, posing a significant barrier to the adoption of digital technologies. Regulatory challenges also play a crucial role, with diverse and often stringent regulatory environments across Latin America complicating uniform digital strategy implementation. There is also a notable gap in workforce readiness. A significant portion of the workforce is yet to fully embrace and utilize new digital tools effectively, which underscores the need for comprehensive training and development programs.

The Promise of a Holistic Approach and the Role of SMEs

The panel emphasized the importance of a holistic approach to digital transformation, which involves not just adopting new technologies but also considering cultural, organizational, and process changes. This strategy ensures that digital tools are seamlessly integrated into existing workflows, enhancing operational efficiency and improving patient care.

Small and Medium-sized Enterprises (SMEs) also play a crucial role in the region’s pharmaceutical sector. Digital transformation can empower these enterprises by providing tools to improve efficiency, market reach, and innovation. However, SMEs often face more significant challenges in adopting digital technologies due to limited resources and expertise, which requires tailored strategies to support their digital journey.

Navigating the Future: Omnichannel Strategies and Patient-Centric Approaches

A significant part of the discussion also revolved around the effectiveness of omnichannel versus multichannel strategies. The panel agreed that an omnichannel approach, which provides a cohesive and integrated customer experience across all touchpoints, is more effective in meeting the complex needs of healthcare professionals and patients. 

To emphasize the growth and effectiveness of omnichannel strategies in the region, and highlight how these strategies have evolved and become more crucial during the pandemic, Susana Bento notes:

“The use of Omnichannel digital, of course, has exploded with COVID […] but it was something that I already saw growing.”

The future of digital transformation in Latin America’s pharmaceutical industry looks promising. The panel discussed a future where digital tools are fully integrated into the industry, regulatory environments are more harmonized, and the workforce is well-prepared to utilize these technologies, driving significant advancements in healthcare delivery.

Conclusion

The webinar provided rich insights into the challenges and opportunities presented by digital transformation in Latin America’s pharmaceutical industry. By addressing the unique obstacles and leveraging the opportunities, the region can achieve significant progress in healthcare. The future holds promise for a fully integrated digital ecosystem, harmonized regulations, and a well-prepared workforce, ultimately leading to improved healthcare delivery and patient outcomes.

About Platforce

Platforce’s cloud-based CRM and CLM makes full sales cycle management for Pharmaceutical and Life Science companies completely painless. Book a demo of Platforce with our team to learn more!

Unlocking Omnichannel Excellence with AI-Driven Strategies: Pharma Talk Show Webinar Series

Speakers and Moderators


In the rapidly evolving pharmaceutical and life sciences industries, embracing omnichannel strategies powered by artificial intelligence (AI) is no longer optional—it’s imperative. The recent episode of Pharma Insights, hosted by Platforce, delved into this critical topic with industry experts Ben Keppie, James Turnbull, and Manuel Mitola. Their discussion highlighted how AI-driven omnichannel approaches can transform healthcare professional (HCP) engagement, personalize customer experiences, and boost sales effectiveness.

Watch the full webinar recording:

The Power of Omnichannel in Pharma

Omnichannel strategies enable pharma companies to reach HCPs through multiple touchpoints, creating a seamless and integrated experience. As Manuel Mitola emphasized, the goal is to personalize interactions and ensure consistency across all channels. This approach not only enhances HCP engagement but also drives better outcomes in patient care.

Ben Keppie provided insights into the practical implementation of omnichannel strategies, pointing out that the essence lies in connectivity and relevance. One of the tenets of omnichannel is connectivity, he explained. “We were just discussing a lot of content that we put on websites that has no next step. Even giving recommendations is better than nothing.” If you launched Netflix and it was just a blank screen (instead of recommended things to watch), it would be very confusing, explains Keppie. So, providing options, even if they aren’t perfect, keeps the engagement going​​.

AI’s Role in Enhancing Efficiency

Artificial intelligence plays a pivotal role in optimizing omnichannel strategies. AI can analyze vast amounts of data to provide actionable insights, enabling pharma companies to tailor their marketing efforts more precisely. James Turnbull highlighted the significance of AI in streamlining processes and supporting decision-making. AI technologies that are being commercialized are very much positioned as supporters to roles, like taking the field teams, for example. There’s a rise in virtual sales assistants that empower people to be more effective.

AI-driven tools can identify patterns in HCP behavior, allowing marketers to deliver personalized content at the right time. This not only improves the relevance of the information provided but also enhances the overall HCP experience.

Overcoming Channel Integration Challenges

Integrating various channels to create a cohesive omnichannel strategy comes with its set of challenges. The speakers acknowledged that achieving seamless integration requires a well-thought-out approach and robust technology infrastructure. James Turnbull shared practical tips on effectively using AI to manage and integrate multiple channels. He stressed the importance of strategic planning and focusing on relevant content delivery rather than over-personalization, which can sometimes come off as invasive.

The future isn’t about hyper-personalization for its own sake, note the speakers. It’s about creating a personalized journey. Everyone gets the same content, but the way they interact with it differs. This approach ensures that HCPs receive relevant information “without feeling like they’re being stalked”​.

Personalizing HCP Interactions

Personalization is a cornerstone of effective omnichannel strategies. By leveraging AI, pharma companies can understand HCP preferences and behavior patterns, allowing them to deliver tailored messages. However, as the speakers pointed out, personalization should be done thoughtfully to avoid overwhelming HCPs with irrelevant content.

AI is a helpful key in balancing personalization with choice. The crucial thing is to give choice. Netflix doesn’t tell you ‘you should only watch this,’ it says ‘here are five things you might like.’ This principle can be applied to HCP engagement, offering them relevant options without being prescriptive.

Future of Omnichannel in Pharma

The future of omnichannel strategies in pharma looks promising, with AI playing an increasingly significant role. The integration of AI and omnichannel approaches is expected to evolve, providing more sophisticated tools for engagement and data analysis. The speakers highlighted that ongoing advancements in AI technology would enable even more precise targeting and efficient resource allocation.

They discussed the potential of AI in transforming sales teams. As there’s a rise in virtual sales assistants like Co-Pilot from Actana or My AiDEA from True Blue are designed to support sales teams, making them more efficient and effective. It’s about doing their job better and smarter​​.

Practical Insights and Takeaways

  1. Relevant interconnectivity: Ensure that all channels are interconnected and provide relevant content to maintain HCP engagement. The cross-team design of digital tools adopted can ensure a high degree of flexibility in personalizing messages.
  2. AI-powered support: Utilize AI-driven tools to support sales teams and streamline processes. Rather than replacing human roles, tools that integrate AI in their systems can offer enhanced sales monitoring.
  3. Balanced personalization: Focus on creating a personalized journey for HCPs, offering them relevant options without overwhelming them.
  4. Strategic integration: Plan the integration of various channels strategically, ensuring that the technology infrastructure supports seamless communication.
  5. Future prospects: Stay updated with AI technology developments and aim to continuously enhance omnichannel strategies and improve HCP engagement by leveraging the power of existing technologies.

Conclusion

The insights from this episode of Pharma Insights underscore the transformative power of AI-driven omnichannel strategies in the pharmaceutical and life sciences industries. By focusing on connectivity, relevance, and thoughtful personalization, pharma companies can significantly enhance HCP engagement and drive better outcomes in patient care. 

About Platforce

Platforce’s cloud-based CRM and CLM makes full sales cycle management for Pharmaceutical and Life Science companies completely painless. Book a demo of Platforce with our team to learn more!

Startups vs Corporations: Pharma Talk Show Webinar Series

In the ever-evolving landscape of the pharmaceutical and life sciences industries, understanding the operational dynamics between startups and large corporations is crucial. The second episode of Platforce’s Pharma Insights webinar series, “Startups vs Corporations: Differences in Modus Operandi,” looked at such contrasts, offering valuable insights from industry experts Dr. Yvette Schollmeier, Founder of Q&C at Schollmeier, and Martijn van den Corput, CEO at OptInsight.

Hosted by Platforce’s Head of Marketing, Stefan Repin, and Events Manager, Juliana Maria Kreisel, the webinar opened with a discussion on the fundamental differences between large corporations and startups in the pharma industry. Dr. Schollmeier and Mr. van den Corput shared their extensive experiences, highlighting the unique challenges and advantages each type of organization faces.

Watch the full webinar recording:

Flexibility and Speed: The Startup Advantage

Startups, by nature, are agile and more willing to take risks, which can be a significant advantage in the fast-paced pharma industry, noted Dr. Yvette Schollmeier: 

“Startups are more flexible and faster, willing to adjust and adopt digital customer relation management systems”​​.

This flexibility allows startups to innovate rapidly, implement new technologies, and adapt to market changes more swiftly than their larger counterparts. Martijn van den Corput echoed this sentiment, highlighting that startups often have a greater sense of urgency due to limited resources and the need to prove their viability quickly:

“There is more pressure on results in startups because they have more to prove,” he noted​​. 

This pressure can drive startups to achieve remarkable feats in shorter timeframes, pushing the boundaries of innovation and efficiency.

The Corporate Strength: Resources and Stability

On the other hand, large corporations possess significant resources, including funding, established infrastructure, and extensive networks. These assets can provide stability and enable large-scale operations that startups might struggle to achieve. Dr. Schollmeier pointed out that big corporations, although slower to adapt, have the financial muscle to invest in comprehensive R&D and long-term projects without immediate financial pressure​​.

However, this stability often comes with a cost: slower decision-making processes and a tendency to stick to traditional methods. The bureaucracy inherent in large corporations can hinder their ability to pivot quickly in response to new opportunities or threats. This was highlighted during the webinar, where the speakers discussed the challenges large corporations face in embracing digital transformation and innovative technologies​​.

Regulatory Compliance and Quality Management

Both startups and corporations in the pharma industry must navigate a complex web of regulations and quality management standards. Dr. Schollmeier shared her experiences working in both environments, noting that while the regulatory requirements are similar, the approach to compliance can differ significantly. Startups, driven by the need to establish themselves, may adopt more innovative compliance strategies, leveraging digital tools to streamline processes. In contrast, corporations might rely on established, albeit slower, procedures that ensure compliance but may lack the agility of their smaller counterparts​​.

Marketing Strategies: Tailoring to the Audience

Marketing in the pharma industry presents unique challenges, especially given the stringent regulations surrounding drug promotion. Startups often need to be more creative and aggressive in their marketing efforts to build brand awareness and acquire clients. They tend to leverage digital marketing and social media more effectively, reaching their target audiences with tailored messages.

Dr. Schollmeier highlighted the importance of understanding and adapting to these regulations, sharing that “marketing in highly regulated industries like pharma requires a nuanced approach, balancing compliance with creativity”​​. Startups, with their nimble structures, are often better positioned to experiment with innovative marketing strategies, whereas corporations may stick to more traditional methods.

AI and Machine Learning: A Double-Edged Sword

The integration of AI and machine learning in pharma is another area where startups and corporations diverge. Startups are generally more open to adopting these cutting-edge technologies, using AI for tasks ranging from drug discovery to personalized marketing. This willingness to embrace AI can provide startups with a competitive edge, allowing them to operate more efficiently and innovate continuously.

Conversely, large corporations, while recognizing the potential of AI, may be slower to implement these technologies due to the scale of their operations and the inherent risk aversion in their organizational culture. Martijn van den Corput pointed out that “big pharma companies are often skeptical and reluctant to use cloud-based AI services for drug design,” highlighting the cautious approach of larger entities towards new technologies​​.

The Path Forward: Collaboration and Innovation

The webinar concluded with a discussion on the potential for collaboration between startups and corporations. Both Dr. Schollmeier and Mr. van den Corput agreed that fostering partnerships could lead to mutually beneficial outcomes, combining the agility and innovation of startups with the resources and stability of corporations. By working together, these organizations can accelerate the pace of innovation, improve regulatory compliance, and ultimately deliver better outcomes for patients.

Final Thoughts

The differences between startups and corporations in the pharma industry are stark, each with its unique strengths and challenges. Startups bring flexibility, speed, and a willingness to embrace new technologies, driving rapid innovation and adaptability. In contrast, corporations offer stability, extensive resources, and established processes, ensuring compliance and sustained growth.

As the pharma landscape continues to evolve, understanding these differences and leveraging the strengths of both types of organizations will be crucial. By fostering a collaborative ecosystem, the industry can harness the best of both worlds, driving forward innovation and delivering improved healthcare solutions globally.

About Platforce

Platforce’s cloud-based CRM and CLM makes full sales cycle management for Pharmaceutical and Life Science companies completely painless. Book a demo of Platforce with our team to learn more!

Unlocking the Future of Pharma CRM with AI: Insights from – Pharma Talk Show Webinar Series

In the ever-evolving pharmaceutical industry landscape, staying ahead requires constant innovation and adaptation. One of the most transformative tools at our disposal today is Artificial Intelligence (AI). Platforce hosted a webinar titled Is AI the Solution to Pharma CRM Challenges? that explored the potential of AI to revolutionize Customer Experience Management (CXM) in the pharma sector. The session brought together industry experts who shared their insights on balancing data, AI developments, and human creativity and explored ways to foster collaboration between sales and marketing teams.

Watch the full webinar recording:

Watch the full recording on our webinar page

Meet the Experts:

  • Claudia Adreani, Independent Consultant at Belly Slide Consulting, brings over a decade of experience in the pharmaceutical industry, including strategic roles at AstraZeneca and Boehringer Ingelheim.
  • Dan Buckland, Director at Brandcast Health, specializes in medical marketing and communications, with a keen focus on content strategy and delivery.
  • Florent Edouard, SVP, Global Head of Commercial Excellence at Grünenthal Group, has extensive experience in leveraging data and AI to drive commercial success in the pharmaceutical industry.
  • Stefan Repin, Head of Marketing at Platforce, guided the discussion with insightful questions and facilitated a dynamic exchange of ideas.

Introduction to the Promise of AI in Pharma CRM

The webinar began with an introduction by Stefan Repin, who set the stage by highlighting the immense potential of AI in transforming Pharma CRM. He emphasized the need for the industry to move beyond traditional CRM systems and use the power of AI to gain deeper insights into customer behaviour and preferences.

Data Analysis with AI Transforms Insights into Action

The first segment of the webinar focused on the role of AI in data analysis. Florent Edouard kicked off the discussion by sharing his experiences and challenges with CRM systems in the pharma industry. He highlighted the importance of aggregating data from various channels to understand customers better and pivot strategies accordingly.

“Without the help of tools like generative AI, the wealth of data you have to manipulate to be able to decide if Dr. Rein wants to have information on safety or efficacy is enormous. No human being can compute that.” – Florent Edouard

Florent explained that AI could process vast amounts of data quickly, enabling companies to personalize their interactions with healthcare professionals (HCPs) more effectively. He stressed that while AI could handle data analysis, human oversight is essential to ensure the insights are applied correctly.

CRM Data will Bridge the Gap between Sales and Customers

Next, the conversation shifted to the practical use of data in CRM. Dan Buckland discussed the common pitfalls in the industry, where the full potential of CRM systems often goes untapped. He emphasized the need for marketers and account managers to understand their CRM systems’ capabilities fully and integrate strategic data points to enhance customer relationship management.

“I think people don’t understand the capability of their own CRMs right now. It’s crucial to strategically design your CRM to capture the right data about your customers.” – Dan Buckland

Dan pointed out that many companies use CRM systems merely as call logs for sales reps, missing out on the strategic benefits that these systems can offer. He called for a shift in mindset, where data from CRM systems is used proactively to drive marketing and sales strategies.

Creating a Content Strategy with AI: How to Combine Data with Creativity

One of the most intriguing parts of the webinar was the discussion on creating a content strategy with AI. Claudia Adreani shared her insights on balancing AI’s data-driven capabilities with human creativity. She explained how AI could analyze customer data to provide insights and recommendations, but human input is necessary to ensure the content resonates with the target audience.

“I think that the essential work of humans vetting the creativity level. […] I don’t think we need to just leave it to devices but it (AI) definitely has got a lot of capacity to help.”​- Claudia Adreani

Claudia highlighted the need for a collaborative approach, where AI provides data-driven insights and humans add the creative touch to develop compelling content strategies. This blend of AI and human creativity can result in more engaging and effective content that meets the needs of the audience.

Will AI Improve Collaboration Between Sales and Marketing Teams?

A key theme of the webinar was the importance of collaboration between sales and marketing teams. The panellists discussed how AI could facilitate this collaboration by providing data-driven insights that align both teams’ strategies towards common goals. Successful CRM strategies depend on the collaboration between sales and marketing teams. AI can facilitate this by providing insights that help align their efforts towards common goals, suggested the panellists.

The experts agreed that a unified approach, supported by AI-driven insights, could lead to more effective CRM strategies and better business outcomes. They emphasized the need for regular communication and data sharing between teams to ensure that everyone is working towards the same objectives.

Audience Q&A: Addressing Real-World Challenges

The webinar concluded with a Q&A session, where the panellists addressed various audience questions. One of the key topics was the practical application of AI in CRM and the challenges of integrating AI tools into existing systems. While AI can process and analyze large datasets to provide actionable insights, human creativity and intuition are essential for developing strategies that truly connect with customers remarked the speakers.

The panellists also discussed future trends in the industry, highlighting the potential of AI to drive even greater innovation and efficiency in CRM systems. They stressed the importance of continuous learning and adaptation to stay ahead in the rapidly changing pharma landscape.

Key Takeaways

The Platforce webinar provided a comprehensive overview of how AI can revolutionize CRM in the pharma industry. Here are some key takeaways:

  • AI can process and analyze large datasets to provide actionable insights. However, human creativity and intuition are essential for developing strategies that truly connect with customers.
  • Integration of AI in CRM: AI enhances CRM systems by enabling more personalized customer interactions. This requires clean data and a strategic approach to integrating AI tools.
  • Successful CRM strategies depend on the collaboration between sales and marketing teams, facilitated by AI-driven insights that help align their efforts towards common goals.
  • The industry must continuously adapt and learn to stay ahead in the rapidly changing landscape. This includes staying updated with the latest AI developments and integrating them into CRM strategies effectively.

This detailed exploration of AI’s role in Pharma CRM highlights the transformative potential of AI in the industry. By combining data-driven insights with human creativity and fostering collaboration between sales and marketing teams, pharma companies can enhance their CRM strategies and achieve better business outcomes.

About Platforce

Platforce’s cloud-based CRM and CLM make full sales cycle management for Pharmaceutical and Life Science companies completely painless. Book a demo of Platforce with our team to learn more!

Step-up Pharma Sales Performance and Close Deals Faster

Pharma sales performance refers to measuring and evaluating the effectiveness and efficiency of pharmaceutical sales teams, representatives, or organisations in achieving their sales goals, targets, and objectives.

If you’ve witnessed the pharma business landscape after the pandemic, you can attest to the rigorously competitive nature of this landscape. Amongst several factors that make for a win, the effectiveness of your business’s sales team plays a critical role in driving revenue growth and market share. 

With the United States pharma market alone generating a revenue of over $670 billion, it’s okay to say every strategic effort invested into your sales team is worth it. Interestingly, the pharma market doesn’t tow a straight path but evolves. Customer needs change, and it’s only logical that your sales teams adapt and innovate to stay ahead in these times.

To catch a holistic view of current trends and needs in pharma sales, we discussed with Lucas Hrovat, Senior Manager for Commercial Execution at Abbott (LATAM & Canada), and  Nuno Melo Moreira, Executive Managing Consultant & VP of strategy sales, NHS. 

Through their expert insights and real-world examples, we delve into successful sales strategies and campaigns, metrics for assessing sales force effectiveness, adapting sales strategies to diverse market needs, overcoming unique sales challenges, and effective technologies and tools for boosting sales performance. Let’s jump in! Here are 5 ways to achieve better results.

1. Successful Pharma sales performance requires strategies and campaigns

Every business needs a proactive sales strategy, and pharma businesses aren’t an exception. While being conclusive and decisive in your approach is important, the winning sales strategies are the ones which from design are built to show good flexibility about your team’s advancements, and which can easily adapt to changing external conditions, such as market fluctuations or political decisions.

Mr Nuno Melo Moreira shared his experience leading a successful sales strategy during his company’s European rebranding process, where they transformed from Merck Generics to the American Mylan Group. He emphasized that successful sales strategies involve understanding customer needs, addressing prices early, implementing high-converting sales proposals, driving decision-making with mutual action plans, and understanding stakeholders’ concerns. 

This can significantly shorten the sales cycle and improve sales performance. In his words, We approach prices at the beginning of the sales process. Unqualified opportunities can lengthen the cycle, so being transparent about costs helps filter out unsuitable prospects.”

2. Metrics for Assessing Pharma Sales Performance through Sales Force Effectiveness

Pharma sales performance can be assessed through quantifiable metrics, which are highly dependant on the company’s specific business model. From a sales force effectiveness perspective, pharma sales performance refers to the efficiency and productivity of pharmaceutical sales teams in achieving their sales objectives, building strong customer relationships, and driving business growth. 

These teams, often referred to as “field forces” or “sales reps,” are deployed across various regions and territories to promote products, engage with healthcare professionals, and gather insights from the market.

To maximize sales efforts, It’s essential to identify and track your business’s key metrics with Closed-loop marketing (CLM) tools like Platforce. Effectiveness in Pharma sales today means you can analyze your sales process and know how much revenue and customer satisfaction it brings to your company. 

For Mr Moreira, metrics such as reach and frequency, total prescriptions (TRx), new to the brand (NBRx), sales quota achievement, and time to initiation are of high priority. He also highlights manager evaluation, interaction skills, and emotional intelligence (EI) as vital metrics to assess pharma sales performance through sales force effectiveness in the pharmaceutical sector. 

He emphasizes adapting these metrics to each company’s unique context. According to Nuno, Understanding customers’ emotions and needs generates trust. Empathetic representatives adapt their approach, which leads to stronger relationships and successful sales.”

3. Diversify Sales Strategies to Reflect Market Needs

Every market has unique opportunities and challenges, especially in the ever-dynamic Pharma and life-science industries. One of the keys to success for a multinational pharma company could mean understanding how to tailor sales strategies to meet the unique needs of different markets and customer segments. 

For some, it could come as a surprise to hear that the pharma and health industry spent up to $17.8 billion on digital advertising in 2023. With so many funds invested in sales, marketing, and advertising, maximizing data analytics and closed-loop marketing (CLM) tools like Platforce isn’t just a good strategy but a necessity. Why? Because 

We asked Mr Lucas Hrovat how he’s adapted sales strategies to meet diverse market needs across LATAM and Canada. He stressed the need to align sales strategy with corporate strategy, focusing on the product mix, prioritizing, and benchmarking incentives and compensation sales reps.. 

He also highlighted the importance of talent retention and aligning performance KPIs with desired behaviors. In his words,Benchmarking incentives and compensation with market standards can ensure competitiveness. It is crucial to focus on the product mix. Emphasizing products with higher gross margins can enhance profitability.”

4. Overcoming Unique Sales Challenges in Pharma and Life Sciences

It’ll be presumptuous to venture into the pharma business and not expect daunting challenges that may sometimes seem insurmountable. A few of these challenges, as revealed by Mr. Lucas, are onboarding and continuous learning, work-life balance, and meeting sales targets. The mere passage of time is not on your side, as a business manager. But your main advantage has a lot to do with your proactivity in facing such challenges.  

“The pressure of work culture can compromise balance. It’s crucial to separate “work time” from “personal time.” Enhancing productivity during work hours is key to relaxing properly afterwards,” says Lucas Hrovat.

In his view, overcoming these challenges requires well-structured training programs, setting clear goals, and leveraging CRM technology. He also specified that effective sales leaders prioritize talent retention, continuous learning, and work-life balance to drive sales performance. 

5. Effective Technologies and Tools for Field Force Teams

Unlike others, the pharma and life science industries have been slow to adopt cutting-edge technologies for marketing purposes due to reasons such as harsh regulatory landscapes which require carefulness regarding compliance. 

Nonetheless, it’s unarguably true that tech is here to stay, hence, every pharma business leader should be forward-thinking and make prompt decisions about integrating tech to boost sales performance, while not breaking the traditional “rules of the game” specific to pharma and life science products.

“Regarding key tools, I prefer CRM combined with analysis tools. The most motivating thing is to have a clear goal and KPIs to measure your progress,” says Lucas Hrovat.

At Platforce, we strive to give you a holistic and catered blend of data analysis tools, seamlessly integrated into our CRM platform. Interestingly, you also don’t have to worry about saving important metrics when your field force teams run out of internet – our product works offline and can synchronise data as soon as Internet access is restored, making updates accessible across and within teams. 

How to enhance pharma sales in just a few steps

In conclusion, pharma sales performance has everything to do with your salesforce effectiveness. But, enhancing sales team performance and accelerating sales cycles in pharma and life sciences requires a multifaceted approach that carefully analyzes your specific business needs and team dynamics- no one-size-fits-all. 

By implementing successful sales force effectiveness strategies and analytics, such as tracking key metrics, adapting to diverse market needs, overcoming unique challenges, and leveraging effective technologies and tools, your sales teams will stay ahead of the competition and drive business growth. 

As the industry continues to evolve, your sales teams must remain agile, innovative, and customer-focused to succeed. By embracing the five key strategies mentioned above, your sales teams will optimize performance, accelerate sales cycles, and ultimately improve communications with Healthcare Professionals (HCPs) and other stakeholders. Learn more about the art of detailing to doctors and building strong pharmaceutical relationships.

Platforce is a cutting-edge digital solution for the pharma and life science industries, bringing to the table rich data management experience which your sales team needs to effectively navigate the complex pharma market in 2024. Take the bold step with us today and see an unprecedented transformation in your business!

Get a free personalized salesforce effectiveness analysis audit from our experts to develop a step-by-step plan to review your current opportunities and identify areas for improvement.

The author of this blog post is Japheth, a seasoned B2B SaaS writer who drives growth and engagement for innovative software companies through compelling stories and content marketing solutions. When he isn’t writing, he’s reading a good book or chilling out with friends.